China Reform (China) Today
| 000503 Stock | 10.06 0.44 4.19% |
Performance1 of 100
| Odds Of DistressLess than 23
|
China Reform is trading at 10.06 as of the 4th of January 2025, a 4.19 percent decrease since the beginning of the trading day. The stock's open price was 10.5. China Reform has about a 23 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 5th of December 2024 and ending today, the 4th of January 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 5th of October 1991 | Category Healthcare | Classification Health Care |
China Reform is entity of China. It is traded as Stock on SHE exchange. The company has 981.31 M outstanding shares. More on China Reform Health
Moving against China Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
China Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. China Reform's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding China Reform or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President | Wei Han | ||||
| Thematic Idea | Health Management (View all Themes) | ||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, Health Management, Health Care, Health Care Providers & Services, Health Care Equipment & Services, Health Care (View all Sectors) | ||||
China Reform's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to China Reform's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsChina Reform can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand China Reform's financial leverage. It provides some insight into what part of China Reform's total assets is financed by creditors.
| |||||
China Reform Health (000503) is traded on Shenzhen Stock Exchange in China and employs 1,420 people. China Reform is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.87 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate China Reform's market, we take the total number of its shares issued and multiply it by China Reform's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. China Reform Health operates under Health Care Providers & Services sector and is part of Health Care industry. The entity has 981.31 M outstanding shares.
China Reform generates negative cash flow from operations
Check China Reform Probability Of Bankruptcy
Ownership AllocationChina Reform holds a total of 981.31 Million outstanding shares. China Reform Health retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check China Ownership Details
China Reform Health Risk Profiles
Although China Reform's alpha and beta are two of the key measurements used to evaluate China Reform's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.11 | |||
| Semi Deviation | 4.02 | |||
| Standard Deviation | 5.21 | |||
| Variance | 27.15 |
China Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in China Reform without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
China Reform Corporate Management
Elected by the shareholders, the China Reform's board of directors comprises two types of representatives: China Reform inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Reform's management team and ensure that shareholders' interests are well served. China Reform's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Reform's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Zhongsheng Wang | General Officer | Profile | |
| Yonghua Li | NonIndependent Mang | Profile | |
| Qin Xiao | S Board | Profile | |
| Hongquan Yuan | General Manager | Profile | |
| Liqun Sun | Deputy Manager | Profile | |
| Wenchang Wang | Chief Accountant | Profile |
Other Information on Investing in China Stock
China Reform financial ratios help investors to determine whether China Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Reform security.